Subscriber Content Read Preview
Allergan's stomach-shrinking Lap-Band won a favorable vote from a federal advisory panel, showing how surgery rather than drugs is increasingly gaining favor as a treatment for obesity.
Subscriber Content Read Preview
U.K.-based AstraZeneca and Swiss drug maker Nycomed confirmed that European Union regulators had raided some of their offices this week in connection with an antitrust probe.
Subscriber Content Read Preview
The Japanese government Friday confirmed the country's first outbreak of a high-risk bird flu in three years. The report came two weeks after Hong Kong reported the first human case there since 2003.
Subscriber Content Read Preview
A judge temporarily blocked CVS Caremark's hiring of a new president of retail operations after Wal-Mart filed a lawsuit to prevent his employment.
Subscriber Content Read Preview
Momenta sued Teva over patents related to the blockbuster rapid-acting heparin called enoxaparin.
Subscriber Content Read Preview
Merck is expected to announce a deal to buy a closely held biotechnology company in the early stages of developing a new diabetes treatment.
Subscriber Content Read Preview
U.S. pharma giant Johnson & Johnson said it plans to proceed with its agreed €1.75 billion ($2.27 billion) cash takeover offer for Crucell, maintaining the option to change terms.
Subscriber Content Read Preview
Glaxo is nearing a deal to buy Nanjing MeiRui Pharma, a Chinese drug company that would boost its exposure to the fast-growing market.
Subscriber Content Read Preview
Glaxo formally terminated a clinical trial of an experimental drug designed to harness the benefits of red wine, saying it isn't planning further testing.
Subscriber Content Read Preview
A panel said drugs used to treat enlarged prostates in men shouldn't be used to prevent prostate cancer.
Subscriber Content Read Preview
Eurand agreed to be acquired by Axcan Holdings for $583 million, after an "extended auction process" for the Netherlands specialty pharmaceutical company.
Subscriber Content Read Preview
The FTC challenged Laboratory Corp. of America Holdings' $57.5 million acquisition of Westcliff Medical Laboratories, alleging the deal would harm competition in southern California.
The Senate approved a long-delayed bill to give the FDA new food-safety authority, and the House is expected to pass the measure by the end of the year.
Subscriber Content Read Preview
Merck board named Kenneth Frazier as its new chief executive starting Jan. 1, while current Chief Executive Richard Clark will continue as chairman.
Subscriber Content Read Preview
Novartis plans to cut about 1,400 jobs at its U.S. general-medicines unit.
Subscriber Content Read Preview
China's top economic planning agency said it will slash the maximum retail prices of some medicines by an average of 19% starting on Dec 12.
Subscriber Content Read Preview
The FDA said a proposed thyroid cancer drug being developed by AstraZeneca was associated with "substantial toxicity."
The American Red Cross says that as a result of concerns over XMRV, it is barring people with a diagnosis of CFS from donating blood.
For economists, it's important to figure out whether amenities add value to society, three researchers say.
It's too early to say for sure how hard the flu will hit this year, but the number of confirmed cases is beginning to increase in the southeast, the CDC says.
The FDA has already refused to approve two other weight-loss drugs, Vivus's Qnexa and Arena's lorcaserin, without more data.
Chef Quinn Hatfield of Los Angeles trains for competitive track cycling at a velodrome with an Olympic coach.
Journal articles on nation-wide flu vaccination in 1976:
There really are just two kinds of people in the world—talkers and non-talkers. Complicating relationships: Many non-talkers are also non-listeners—they simply tune out the chatter.
For struggling New York actors reduced to waiting tables for a living, there's finally an alternative career path: bedbug hunter.
How much is a life worth? Economists lately have been putting a price tag on social ills ranging from murder to smoking to drug abuse. The numbers can be shocking, but they also risk greatly oversimplifying problems.
Joe Queenan, flu-shot fearer, gets a flu shot—and then gets really, really sick. Coincidence? He has to wonder....
Recent research illustrates how writing by hand engages the brain in learning. And in an interesting twist, new technology is starting to reinvigorate this age-old practice.
Get in-depth research on Health companies, including complete news and financials, earnings estimates and more.
The latest news and analysis delivered to your in-box. Check the boxes below to sign up.
Hello
Your question to the Journal Community Your comments on articles will show your real name and not a username.Why?
Create a Journal Community profile to avoid this message in the future. (As a member you agree to use your real name when participating in the Journal Community)